Cell Therapy & Gene Therapy Equipment calculator
Cell Therapy Batch Failure Cost Calculator
Cell Therapy Batch Failure Cost estimates the expected dollar loss from GMP batch failures across a campaign, combining the probability of failure with the direct cost of each lost batch. Quality, manufacturing, and finance leaders in cell and gene therapy rely on it because a single failed autologous lot can cost six figures and, worse, leave a patient without their dose. It matters because failure cost is often invisible until it shows up as scrapped product and CAPA spend; sizing it upfront justifies investment in contamination control, operator training, and process robustness. The calculator also reports expected loss per planned batch, turning campaign risk into a per-lot figure you can build into pricing and reserves.
What this calculator does
- Estimate expected financial exposure from failed, contaminated, or unreleased cell therapy and gene therapy batches.
- a quality or operations team is estimating the cost impact of expected batch failures in a GMP production plan
- It computes expected failure cost as planned batches times direct cost per failed batch times failure rate, plus a fixed deviation or remediation cost.
Formula used
- Variable failed-batch loss = planned GMP batches × direct cost per failed batch × expected batch failure rate
- Expected batch failure cost = variable failed-batch loss + fixed deviation or remediation cost
Inputs explained
- Planned GMP batches at risk:
- Direct cost per failed batch:
- Expected batch failure rate:
- Fixed deviation or remediation cost:
How to use the result
- Use it when planning a campaign, setting cost reserves, or building the business case for quality and contamination-control investments.
- It uses an average failure rate applied uniformly, so it does not capture clustered failures, learning curves on new processes, or the patient and reputational cost of a missed autologous dose.
Current U.S. benchmarks
- U.S. manufacturing runs at 75.6% of capacity with new factory orders at $657B per month (Federal Reserve and Census, May 2026).
- Steel mill PPI stands at 348.53 (BLS, May 2026), up 6.7% from a year earlier. New factory orders are up 2.3% year over year (Census).
Common questions
- How do you calculate expected batch failure cost? Multiply planned batches by direct cost per failed batch and by the failure rate, then add fixed remediation cost. Here 24 x $185,000 x 8% gives $355,200 variable, plus $45,000 fixed, for $400,200 expected loss.
- What is expected loss per planned batch? It spreads the total expected loss across every batch you plan, failed or not. In the example, $400,200 across 24 batches is $16,675 per planned batch — a useful figure to embed in cost-of-goods or pricing.
- What counts as direct cost per failed batch? Materials, media, viral vector, consumables, suite time, and labor consumed by a batch that never releases. The $185,000 default reflects an expensive cell or gene therapy lot but excludes downstream patient or revenue impact.
- What is a typical GMP batch failure rate? It is highly process- and maturity-dependent. Early clinical cell therapy processes can see 10-20% failure, while mature commercial processes target low single digits. The 8% default reflects a maturing but not fully optimized process.
- Why include a separate fixed deviation cost? Some remediation spend — a planned CAPA program, a contamination investigation, or facility requalification — is incurred regardless of how many batches fail. The $45,000 fixed charge is added on top of the probability-weighted variable loss.
Last reviewed 2026-05-12.